"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
1
Ep167: Leslie Williams on transfer RNA therapies
1:11:28
1:11:28
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
1:03:35
1:03:35
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
1:02:45
1:02:45
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
56:39
56:39
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
1:08:19
1:08:19
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep162: Sean McClain on AI for Biologic Drug Discovery
1:05:59
1:05:59
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep161: Jeff Stein on a Long-Lasting Flu Drug
1:08:51
1:08:51
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep160: Abe Ceesay on Precision Neuroscience
1:08:48
1:08:48
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
1:07:22
1:07:22
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:07:22
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
1:00:44
1:00:44
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:00:44
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
1:02:37
1:02:37
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
1:03:14
1:03:14
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
1:01:43
1:01:43
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep152: Jens Eckstein on Investing in Healthy Aging
1:05:05
1:05:05
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
1:03:55
1:03:55
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
1:03:48
1:03:48
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep149: Nancy Stagliano on Precision Neuroscience
1:01:53
1:01:53
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep148: Diana Brainard on the Fight Against Infectious Disease
1:03:27
1:03:27
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep147: Reid Huber on Investing in the Future of Medicine
1:08:41
1:08:41
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep146: Jeff Huber on Life in Tech and Biotech
1:47:05
1:47:05
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
1:06:39
1:06:39
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep144: Turning the Tables, Rob Perez Interviews Me
1:04:58
1:04:58
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:04:58
Turning the Tables, Rob Perez Interviews MeTimmerman Report tarafından oluşturuldu
…
continue reading
1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
1:10:25
1:10:25
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:10:25
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech FoundersTimmerman Report tarafından oluşturuldu
…
continue reading
1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
55:54
55:54
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
1:09:30
1:09:30
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
1:02:40
1:02:40
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep139: Kevin Conroy on Early Detection of Cancer
1:08:28
1:08:28
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep138: Jodie Morrison on Becoming a Biotech CEO
1:00:17
1:00:17
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep137: Aaron Ring on Immunotherapy for Cancer & More
56:37
56:37
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep136: Deborah Palestrant on Building Biotech Startups
52:52
52:52
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep135: John Maraganore on Developing a New Class of Medicines
1:03:51
1:03:51
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
1:16:22
1:16:22
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
1:10:33
1:10:33
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep132: Eric Dobmeier on Treating Kidney Disease
1:05:44
1:05:44
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep131: Ryan Watts on Neuroscience Drug R&D
1:05:32
1:05:32
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
1:09:29
1:09:29
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
1:11:43
1:11:43
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1:00:34
1:00:34
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep127: Jeb Keiper on Computational Drug Discovery
1:09:41
1:09:41
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep126: DA Wallach on Becoming a Biotech VC
1:11:38
1:11:38
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep125: Barry Greene on a New Drug for Depression
1:04:52
1:04:52
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
1:09:53
1:09:53
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
1:15:26
1:15:26
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
1:00:04
1:00:04
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
1:03:49
1:03:49
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep120: Tim Lu on Gene Circuits for Cell Therapy
1:04:14
1:04:14
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
1:02:42
1:02:42
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.Timmerman Report tarafından oluşturuldu
…
continue reading
1
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
1:08:08
1:08:08
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:08:08
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.Timmerman Report tarafından oluşturuldu
…
continue reading